Advanced search
Publication Cover
Cancer Investigation Volume 41, 2023 - Issue 6
Submit an article Journal homepage
112
Views
2
CrossRef citations to date
0
Altmetric
Article Commentary

Professional Challenges for United States Hematology/Oncology Trainees during COVID-19

Rahul Banerjeea Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington, USA;b Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-3781-5441View further author information
ORCID Icon,
Samuel A. Kareffc Department of Medicine, University of Miami Sylvester Comprehensive Cancer Center/Jackson Memorial Hospital, Miami, Florida, USAORCID Iconhttps://orcid.org/0000-0001-7431-1221View further author information
ORCID Icon,
Yan Leyfmand Department of Medicine, Icahn School of Medicine at Mount Sinai South Nassau, Rockville Centre, New York, USAView further author information
,
Natasha Dhawane Department of Medicine, Section of Hematology and Oncology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USAView further author information
,
Lindsay R. Hammonsf Division of Hematology & Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USAView further author information
,
Aakash Desaig Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USAView further author information
,
Mazie Tsangh Division of Hematology/Oncology, Department of Medicine, Mayo Clinic, Phoenix, Arizona, USAView further author information
,
Ana I. Velazquezi Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, San Francisco, California, USA;j Department of Medicine, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USAORCID Iconhttps://orcid.org/0000-0002-6153-5557View further author information
ORCID Icon &
Amanda Nizamk Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USAView further author information
 show all
Pages 539-547 | Received 09 Nov 2022, Accepted 31 Mar 2023, Published online: 11 Apr 2023
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Abstract

COVID-19 has been devastating for patients with cancer. In this commentary, we chronicle the pandemic’s downstream impacts on United States hematology/oncology trainees in terms of professional development and career advancement. These include loss of access to clinical electives and protocol workshops, delays in research approval and execution, mentor shortages due to academic burnout, and obstacles with career transitions (most notably the post-fellowship job search). While certain silver linings from the pandemic have undoubtedly emerged, continued progress against COVID-19 will be essential to fully overcome the professional challenges it has created for the future hematology/oncology workforce.

Acknowledgments

The authors wish to acknowledge their patients during the pandemic as well as their mentors who persevered as excellent clinicians and teachers.

Author contribution

All authors contributed to manuscript conceptualization and manuscript content. RB wrote the first draft of the manuscript, and all authors provided edits and agreed upon the final version of the manuscript.

Declaration of interest

Dr. Banerjee: Consulting: BMS/Celgene, Genentech/Roche, Janssen Oncology, Sanofi Pasteur, SparkCures; Research funding: Pack Health. Dr. Kareff: Research funding: GMaP Region 3. Dr. Desai: Consulting: Sanofi. Dr. Tsang: Stock ownership, AVEO Pharmaceuticals, Poseida Therapeutics. Dr. Velazquez: Consulting: AstraZeneca; Honoraria: Curio Science, ObR Oncology, MD Outlook, CME Outfitters, MJH Life Sciences, ASCO; Travel: DAVA Oncology, BioAscend, ASCO; Stock ownership: Corbus Pharmaceuticals; Research Funding: National Institute on Aging (under award P30AG015272), National Cancer Institute (under award U54 CA242646-04S2). The remaining authors report no disclosures.

Additional information

Funding

The author(s) reported there is no funding associated with the work featured in this article.

Log in via your institution

Access through your institution

Log in to Taylor & Francis Online

Restore content access

Restore content access for purchases made as guest
Purchase options * Save for later

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,193.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.